FR2444671A1 - Nouvelles quinazolinones, leur preparation et medicament contenant ces substances - Google Patents

Nouvelles quinazolinones, leur preparation et medicament contenant ces substances

Info

Publication number
FR2444671A1
FR2444671A1 FR7931059A FR7931059A FR2444671A1 FR 2444671 A1 FR2444671 A1 FR 2444671A1 FR 7931059 A FR7931059 A FR 7931059A FR 7931059 A FR7931059 A FR 7931059A FR 2444671 A1 FR2444671 A1 FR 2444671A1
Authority
FR
France
Prior art keywords
quinazolinones
new
substances
preparation
medicine containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7931059A
Other languages
English (en)
Other versions
FR2444671B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15576478A external-priority patent/JPS5583761A/ja
Priority claimed from JP12673879A external-priority patent/JPS5651461A/ja
Priority claimed from JP13358279A external-priority patent/JPS5657768A/ja
Priority claimed from JP14198779A external-priority patent/JPS5665877A/ja
Application filed by Individual filed Critical Individual
Publication of FR2444671A1 publication Critical patent/FR2444671A1/fr
Application granted granted Critical
Publication of FR2444671B1 publication Critical patent/FR2444671B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

Nouvelles 4(3H)-quinazolinones substituées sur l'atome d'azote à la position 3 par un radical aromatique. Elles sont caractérisées par la formule générale :
FR7931059A 1978-12-19 1979-12-19 Nouvelles quinazolinones, leur preparation et medicament contenant ces substances Granted FR2444671A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP15576478A JPS5583761A (en) 1978-12-19 1978-12-19 Novel 3-phenyl-4-quinazolone derivative
JP12673879A JPS5651461A (en) 1979-10-03 1979-10-03 Novel 3-phenyl-4-quinazolone derivative
JP13358279A JPS5657768A (en) 1979-10-18 1979-10-18 Novel 4-quinazolone derivative substituted by aromatic residue at 3-position
JP14198779A JPS5665877A (en) 1979-11-05 1979-11-05 Preparation of 4-quinazolone derivative

Publications (2)

Publication Number Publication Date
FR2444671A1 true FR2444671A1 (fr) 1980-07-18
FR2444671B1 FR2444671B1 (fr) 1983-06-10

Family

ID=27471233

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7931059A Granted FR2444671A1 (fr) 1978-12-19 1979-12-19 Nouvelles quinazolinones, leur preparation et medicament contenant ces substances

Country Status (16)

Country Link
US (1) US4276295A (fr)
AR (1) AR225028A1 (fr)
AU (1) AU526309B2 (fr)
CH (1) CH644112A5 (fr)
DD (1) DD150462A5 (fr)
DE (1) DE2950376A1 (fr)
DK (1) DK539979A (fr)
FR (1) FR2444671A1 (fr)
GB (1) GB2040927B (fr)
HU (1) HU182733B (fr)
IT (1) IT1126577B (fr)
NL (1) NL7909118A (fr)
NO (1) NO794135L (fr)
NZ (1) NZ192392A (fr)
SE (1) SE7910376L (fr)
YU (1) YU306379A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056637A1 (fr) * 1981-01-16 1982-07-28 Masayuki Ishikawa 4(3H)-Quinazolinones, leur procédé de production et compositions pharmaceutiques comprenant ces composés
WO2003066603A1 (fr) * 2002-02-06 2003-08-14 Novartis Ag Derives de la quinazolinone et utilisation de ceux-ci comme agonistes des cb

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1161036A (fr) * 1980-05-15 1984-01-24 Masayuki Ishikawa Composes de quinazoline-dione, procede de production et applications en pharmacie
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
EP0293500A1 (fr) * 1987-06-01 1988-12-07 American Cyanamid Company 3-Hétéroalkyl-2,4-quinazoline-diones, 3-hétéroaryl-1,2,3-benzotriazin-4(3H)-ones, 3-hétéroarylalkyl-4-quinazolinone
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
EP0517812A4 (en) * 1990-02-13 1995-10-18 Merck & Co Inc Angiotensin ii antagonists incorporating a substituted benzyl element
US5075313A (en) * 1990-09-13 1991-12-24 Eli Lilly And Company 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
WO1992013535A1 (fr) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Quinazolones substituees a activite anticonvulsivante
US5283247A (en) * 1991-02-06 1994-02-01 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
EP0698013B1 (fr) * 1993-05-12 2001-10-04 E.I. Du Pont De Nemours And Company Pyrimidinones bicycliques fusionnees a pouvoir fongicide
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
US6255311B1 (en) * 1998-01-14 2001-07-03 E. I. Du Pont De Nemours And Company Fungicidal fused bicyclic pyrimidinones
AU2002214546A1 (en) * 2000-09-29 2002-04-08 Cor Therapeutics, Inc. Bicyclic pyrimidin-4-one based inhibitors of factor xa
AU2007202781B2 (en) * 2002-02-06 2010-09-09 Novartis Ag Quinazolinone derivatives and their use as CB agonists
WO2005077905A1 (fr) * 2004-02-13 2005-08-25 Banyu Pharmaceutical Co., Ltd. Dérivé de 4-oxopyrimidine à cycles fusionnés
BR112014025122B1 (pt) * 2012-04-10 2022-08-16 Annji Pharmaceutical Co., Ltd Compostos inibidores de histona deacetilases, composição que compreende os mesmos e usos dos ditos compostos e composição para tratar um tumor associado com a desregulação da atividade de histona deacetilases e aumentar a capacidade de aprendizado

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949975A (fr) * 1972-09-19 1974-05-15
JPS4961183A (fr) * 1972-09-19 1974-06-13

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition
DE1695799C3 (de) * 1967-01-23 1974-10-17 Sumitomo Chemical Co., Ltd., Osaka (Japan) 5-Chlor-3- eckige Klammer auf pyridin-2'-yl eckige Klammer zu -4-(3H)- chinazolinone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949975A (fr) * 1972-09-19 1974-05-15
JPS4961183A (fr) * 1972-09-19 1974-06-13

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1974 *
CA1978 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056637A1 (fr) * 1981-01-16 1982-07-28 Masayuki Ishikawa 4(3H)-Quinazolinones, leur procédé de production et compositions pharmaceutiques comprenant ces composés
WO2003066603A1 (fr) * 2002-02-06 2003-08-14 Novartis Ag Derives de la quinazolinone et utilisation de ceux-ci comme agonistes des cb
EP2319839A1 (fr) * 2002-02-06 2011-05-11 Novartis AG Dérivés de quinazolinone et leurs utilisations en tant qu'agonistes des récepteurs CB
US8552015B2 (en) 2002-02-06 2013-10-08 Novartis Ag Quinazolinone derivatives and their use as CB agonists

Also Published As

Publication number Publication date
AR225028A1 (es) 1982-02-15
FR2444671B1 (fr) 1983-06-10
DK539979A (da) 1980-06-20
IT7928062A0 (it) 1979-12-17
DE2950376A1 (de) 1980-07-10
AU5393279A (en) 1980-06-26
HU182733B (en) 1984-03-28
NL7909118A (nl) 1980-06-23
AU526309B2 (en) 1983-01-06
IT1126577B (it) 1986-05-21
NO794135L (no) 1980-06-20
GB2040927A (en) 1980-09-03
GB2040927B (en) 1983-01-26
YU306379A (en) 1983-12-31
CH644112A5 (de) 1984-07-13
NZ192392A (en) 1983-02-15
DD150462A5 (de) 1981-09-02
SE7910376L (sv) 1980-06-20
US4276295A (en) 1981-06-30

Similar Documents

Publication Publication Date Title
FR2444671A1 (fr) Nouvelles quinazolinones, leur preparation et medicament contenant ces substances
IT9021104A0 (it) Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MX9203543A (es) Medicamento.
NO872686L (no) Nye farmakologiske forbindelser.
DE69127470T2 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
FR2386588A1 (fr) Pigments derivant de l'iso-indoline, leur preparation et leurs applications
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
DE3887544D1 (de) Beta-aminoethyl-substituierte Phenyl-Verbindungen, diese enthaltende entzündungshemmende oder analgetische Zusammensetzungen.
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
FR2383930A1 (fr) Ethers aminoalcoyliques de pyridinyle, leurs procedes d'obtention et preparations pharmaceutiques les contenant
DZ1468A1 (fr) Composés nouveaux.
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
FR2427328A1 (fr) Ethers diphenyliques et medicament contenant ces substances
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
FR2374292A1 (fr) Derives de l'acide 2,5-dihydroxybenzoique et applications a titre de medicament
FR2396756A1 (fr) Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
IT8219804A0 (it) Formulazioni farmaceutiche adattivita' antiinfiammatoria, analgesica, antipiretica e gastroprotettiva.

Legal Events

Date Code Title Description
ST Notification of lapse